Total body water is finely regulated and controls of intake and outptd are maximally activated by small osmotic changes. Sensors in the hypothalamus invoke the fluid repletion or depletion reactions through changes in thirst, urine concentration and solute intake. Antidiuretic hormone controls urinary concentration and is released mainly in response to osmotic stimuli. However, the threshold and sensitivity of this response are affected by non osmotic stimuli. Urine concentration varies in response to antidiuretic hormone only if the distal tubule, collecting duct and hypertonic medullary interstitum are intact. The capacity to conserve or excrete water depends on the osmolar load and an efficient urinary concentrating or diluting mechanism.
INTRODUCTION
Water's unique properties explain why it is an ideal biological solvent. It is highly polar and has a high dielectric constant which allows a stable dissociation of ions necessary for intermediary metabolism. Cell water constitutes 70% of cell mass and is required for structure and organization, whereas extracellular water is required for distribution of nutrients and elimination of excreta.
Body water is passively distributed between the two major compartments in proportion to the compartmental osmolar content. Extracellular and cellular volumes are determined by the total body water content and the relative amounts of potassium (the intracellular cation) and sodium (the extracellular cation). Thus regulation of water metabolism cannot be separated from sodium and potassium homeostasis. Total body water content is finely regulated and controls are maxlmally activated by small changes in osmolality (2%) or water content (2-3 litres). Sensors in the hypothalamus invoke the fluid repletion or depletion reactions through changes in thirst, urine concentration and food (solute) intake.
PHYSIOLOGY OF WATER METABOLISM

Water turnover
Man requires water to eliminate solutes produced by metabolism, and to replace dally insensible fluid losses. Fluid balance is often considered to be the balance between measured water intake and urine output. However, the "unseen" usually exceeds the "seen" fluid turnover, (Table 1) , particularly in the sick patient who has a small urine volume and large Water Turnover (Adapted from Gruber and Allgower 1970) Input Output " Seen" "Unseen" "Seen" " Unseen" skin and lung water loss. Fluid balance charts are therefore poor guides to fluid balance and weight and clinical skills are often more useful. Water turnover depends on osmolar production and the ability to form a dilute or concentrated urine. \Vlth illness these are often abnormal. Hypercatabolic patients have larger obligatory urine outputs, and patients with impaired renal diluting capacity (post operative) are susceptible to a water load (Table 2) .
Daily requirements for water vary greatly, but the average requirement is approximately 1500 ml/m2 (Gruber and Allgower ]970).
Thirst
Most drinking is not prompted by thirst but by social cues or habits and usually exceeds daily needs. \Vhcn access to water is restricted, or solute intake increases, we get thirsty. This follows stimulation of sensitive thirst centres of the ventromedial and anterior areas of the hypo thalamus which integrate relevant stimuli and with cortical influence produces the sensation of thirst (Andersson 1952, Andersson and }lcCann 1956) . The hypothalamic thirst centres lie close to, and are functionally integrated with, the nuclei regulating antidiuretic hormone (A.D.H.). Thus the water repletion reaction causes thirst, secretion of A.D.H. and inhibition of food intake (Stricker 1969) .
Both osmotic and non osmotic factors affect the thirst centre (Table 3) .
Osmoreceptors are sensitive to a 1 % change in body osmolality probably by sensing cell volume changes, caused by water depletion or a solute load which does not enter cells (e.g. sodium). "Effective" extracellular volume is the most important of the non osmolar factors, and if severely depleted will override osmolality. Changes of cardiac output and vascular volume are sensed by intrathoracic, carotid sinus or aortic barocel;tors (Share 1967) , or hy the renin angiotensin system (Fitzsimons 1975) . Information on the "effective" extracellular volume is relayed to the lateral hypothalamus and thence to the thirst centre (Stricker 1969) . Generally however, osmotic and extracellular volume stimuli are complementary.
The response to temperature (Andersson and Larsson ]961) and to hypoxia (Kleeman 1972 ) may be related to increased water requirements and decreased tissue perfusion and oxygenation. Many drugs affect thirst particularly the cholinergic and adrenergic agents (Grossman 1962) . Hypercalcaemia and hypokalaemia increase thirst (Kleeman 1972) and are associated with true polydipsia as well as impairing renal function. 
Synthesis and Mechanism of Secretion
A.D.H. is a nonapeptide (M.W. =1084) which is synthesized in the neuronal cell bodies of the supraoptic and paraventricular nuclei and is packaged in vesicles with a specific carrier protein (neurophysin I). These vesicles move by axoplasmic streaming to the bulbous expansions abutting on capillary basement membranes in the posterior pituitary. The contents of the vesicles are extruded into the capillaries by exocytosis in response to calcium influx caused by membrane depolarization.
Control of Secretion
The human pituitary contains approximately 15 units (30 !kg) of A.D.H. and normally releases 300 mu/d. With dehydration this may increase to 2,000 mu/d and with maximal stress increases transiently to 10-15,000 mu/d. The plasma half life is 16-20 minutes which correlates with the half life of biological effects (Kleeman 1972) .
Osmotic and non osmotic stimuli affect A.D.H. release ( Table 3 ). The response to these stimuli is summarized (Robertson, Shelton and Athar 1976) :
Plasma concentration of A.D.H. = Sensitivity (Plasma osmolality-Threshold) or P ADH =S(P osm -T) =0 ·38 (Pos m -280) pg/ml Both the threshold below which A.D.H. secretion is undetectable (280 mosm/kg) and the sensitivity to osmotic changes can be affected by the non osmotic factors. For example hypovolaemia reduces the threshold and increasing age sensitizes the response (increases S). The urinary response to A.D.H. in normal subjects is: Urinary osmolality =250 (P ADH -0 ·25) mosm/kg. Plasma osmolality is approximately 287 mosmJ kg and A.D.H. concentration is 2 pg/ml. Over the range Pos m 281-296 mosm/kg water the full range of urinary osmolality (30-1200 mosm/kg) occurs with small changes of P ADH (0·4-5 pg/ml).
The osmoreceptor's response to solutes is selective. Solutes which penetrate the blood brain barrier slowly (sodium and mannitol) are potent stimuli, whereas those that penetrate quickly (glucose and urea) have little effect (Robertson and Mahr 1972) . Thus it is not osmolality that is regulated but effective osmolality. This distinction is of practical significance when considering grossly abnormal states (renal failure, hyperglycaemia), although, measured osmolality or osmolarity usually reflect "effective" osmolality.
Regulation of A.D.H. release is primarily by osmotic stimuli, but non osmotic factors affect threshold and sensitivity. Pituitary diabetes insipidus is associated with decreased sensitivity. If thirst is also impaired, polyuria will be absent and a new steady st;;tte will be achieved at the higher Pos m required to obtain adequate A.D.H. levels.
Some patients with inappropriate A.D.H. secretion have a low threshold which has been reset by abnormal impulses from volume receptors (i.e. they have reset their osmostat). In this situation fluid balance is achieved at a decreased P osm .
Renal Water Regulation
A.D.H. controls water output by a high gain feedback loop. In normal subjects a change in p osm of 1 mosm/kg changes urine osmolality by 95 mosm/kg. However, the ability to produce The efficient operation of the countercurrent multiplying system requires several factors (Table 4) .
For example, when glomerular filtration rate is decreased by more than 25%, concentrating ability decreases because there is inadequate delivery of sodium chlonde and urea to the distal nephron. Increasing the solute load decreaSEs concentrating ability by washing out medullary osmoles and shortening the time available for the countercurrent multiplier and collecting duct to act. Diluting ability is decreased because the diluting segment (distal tubule and collecting duct) is flooded. (See Figure 1) .
Similarly, overhydration (hyperdipsia) washes out medullary osmoles and dehydration conserves them (maximum concentrating ability increases from 1200 to 1400 mosm/kg with dehydration for several days). Other hormones effect water excretion but A.D.H. is dominant (Table 5 ). action (Andcrson et al. 1975; Lum et al. 1975; and Berl et al. 1975 In summary, a disturbance of fluid balance invokes a response from hypothalamic cells (osmoreceptors) which release A.D.H. in the posterior pituitary. This acts on the distal tubule and collecting duct system to utilize the osmotic gradient generated by the countercurrent multiplier and produce an appropriately concentrated or dilute urine.
DISORDERS OF THIRST
Secondary hyperdipsia
The common, secondary, or symptomatic hyperdipsia is a physiological response. For example: patients with diabetes insidipus do not become water depleted unless thirst is abnormal or access to water is denied (Table 6 ). In the patient with heart failure a decreased " effective" extracellular volume acts as a physiological non osmotic stimulus for thirst.
Pathological hyperdipsia
(i) Psychiatric disturbances may be associated with hyperdipsia, which may cause hypoosmolality if renal diluting capacity is impaired by drugs (Phillips and Pain 1976) or intrinsic disease. (ii) Central nervous system lesions (tumor, trauma or inflammation) in the hypothalamic thirst area cause hyperdipsia. Hypoosmolality occurs if the osmolar load and urinary diluting capacity are inadequate for the fluid intake. (Rao, Miller and Moses 1975) and chlorpropamide (Bode, Harley and Crawford 1971) have been reported to increase thirst.
Pathologic hypodipsia
This is usually caused by lesions in the supraopticohypophyseal system (tumor, granuloma or trauma) and associated abnormalities of A.D.H. secretion are common (Table 6 ). If both thirst and A.D.H. secretion are affected, marked hyperosmolality will occur. In this form of diabetes insipidus, polyuria does not occur because A.D.H. secretion is stimulated enough to provide an adequately concentrated urine.
DISORDERS OF URINE CONCENTRATION
Diabetes Insipidus
Pathophysiology Damage to the supraopticohypophyseal area produces a triphasic response: an initial block of A.D.H. secretion and polyuria for hours to days; then a "leak" of A.D.H. stores over several days with loss of polyuria and susceptibility to a water load; and finally exhaustion of stores and evolution of total or partial, permanent or transient diabetes insipidus. The occasional patient will respond to non osmotic but not osmotic stimuli. The overall clinical picture is largely determined by the presence or absence of thirst (Table 6 ). 
Aetiology
Half the cases are idiopathic, some are congenital and familial. Of the remainder, most are the result of trauma (hypophysectomy or skull fracture). A few are caused by intra or suprasellar granulomata, inflammation or vascular lesions. Drugs (ethanol, lithium and narcotic antagonists) inhibit A.D.H. release and effectively produce diabetes insipidus (Table 8) .
Clinical FeatltreS
The hallmarks are occurrence at any age, abrupt onset of polyuria and nocturia and hyperdipsia with a preference for cold water. The differentiation from other polyuric syndromes is usually easy. Psychogenic polydipsia is slow to evolve and rarely associated with nocturia. Nephrogenic diabetes insipidus is also slow to evolve and may be distinguished by consideration of its causes (see later). An osmotic diuresis (diabetes mellitus) is excluded by urinalysis.
Diagnostic difficulties do occur. Patients who develop a large bladder capacity may not have nocturia. If glomerular filtration rate is reduced (e.g. postpartum anterior and posterior pituitary infarction) or thirst is absent, the patient may become so dehydrated that normal volumes of adequately concentrated urine are formed.
The diagnosis is made by restricting fluid intake until the patient loses 3-5% of body weight or urine osmolality is constant in three hourly urine collections (some 14 hours after fluid restriction). Aqueous vasopressin (5 u subcutaneously) is then given and urine collected hourly for two hours. In diabetes insipidus there is a further rise in urine osmolality after vasopressin, but in primary hyperdipsia or nephrogenic diabetes insipidus there is no change. These two are separable because primary hyperdipsia is associated with a hypertonic plateau urine osmolality whereas nephrogenic diabetes insipidus is not (Miller et al. 1970) .
Treatment
The choice is between A.D.H. and its analogues or drugs. Pitressin tannate in oil is the time honoured standard (5 ujml; 0·5 ml by deep 11\1 injections on alternate days after warming and resuspending the brown pellet of hormone). In the emergency situation aqueous vasopressin should be used (20 ujml; 0 ·1-0,3 ml, four to six hourly with awareness of pressor effects in patients with ischaemic heart disease). Of the A.D.H. analogues, ]-deamino-8-D-arginine vasopressin (DDAVP) is 2-]00 times as potent as A.D.H. and may altogether supplant injections (10-20 uU as a nasal spray given 12 hourly) (Vavra et al. 1968) .
Drugs are used for mild cases and nephrogenic diabetes insipidus (where A.D.H. is ineffective).
Two groups of drugs which decrease renal diluting capacity (Table 9 ) are useful. Diuretics induce salt depletion, increase proximal sodium reabsorption and therefore decrease delivery of fluid to the distal nephron. Salt depletion is essential for effect. Chlorpropamide (250 mg once or twice daily) increases thirst, increases A.D.H. release and enhances A.D.H. action (Miller and Moses 1970) . It therefore requires some residual A.D.H. secretion to be effective and is not useful in nephrogenic diabetes insipidus. Diuretics and chlorpropamide may be combined.
Nephrogenic Diabetes Insipidus
Two pathophysiological mechanisms may be involved. The distal nephron may lose the capacity to respond to A.D.H. although the generation of the medullary osmotic gradient is normal; or the generation of the osmotic gradient itself may be impaired. A rare congenital form (complete in men and incomplete in women) exists and all patients probably derive from an Ulster Scotsman (Bode and Crawford 1969) . Acquired forms are common and reflect disturbances of factors required by the countercurrent multiplier (Table 4) . A large number of drugs interfere with urinary concentrating capacity (Table 8) as do hypercalcaemia and hypokalaemia F ourman and Lesson 1959). Treatment is of the primary cause with diuretics to reduce urine volume.
DISORDERS OF URINARY DILUTION
By definition these occur when the urine is inappropriately concentrated for the body osmolality.
A.D.H. Excess Syndromes
In general terms, A.D.H. secretion may be " appropriate" for effective extracellular volume or "inappropriate" (Phillips 1975) . " Appropriate" A.D.H. secretion occurs despite hypoosmolality when non osmotic stimuli lower the threshold for A.D.H. secretion. Decreased effective extra-cellular volume occurs in most oedematous states (heart failure, hypoalbuminaemia, venous or lymphatic obstruction) and often " appropriately" lowers the threshold for A.D.H. secretion. "Inappropriate" A.D.H. secretion is less common and can be caused by inappropriate non osmotic stimuli (chest disease), a st~ady hypothalamic or pituitary leak (intra-cranIal dIsease), random A.D.H. secretion (neoplasia), or the secretion of an unknown antidiuretic substance (Robertson et al. 1976) . Some response to osmotic stimuli m?y remain. A new steady state reflects this resetting of the osmostat and the operation of other factors which increase water excretion. For a comprehensive review see Bartter and Schwartz (1967) .
Decreased Urinary Diluting Capacity
Any physiological state or disease which impairs the function of the countercurrent mechanism will decrease diluting capacity (Table 4 ). Many hormones affect urinary diluting capacity (Table 5 ) but only glucocorticoid, mineralocorticoid and thyroid hormone deficiency are clinically important. Apart from the A.D.H. analogues (lysine vasopressin, D.D.A.V.P.),oxytocininfusiondecreasesdiluting capacity and can cause hypoosmolality (Pittman 1963) . Many other drugs directly affect renal diluting capacity (Table 9 ). If the decreased capacity to excrete a water load is exceeded, hypoosmolality will develop. Thus the postoperative patient receiving narcotics and 5% dextrose has a reduced osmolar load (no food intake and inhibition of non fatty tissue breakdown by carbohydrate) as well as a reduced diluting capacity. He is susceptible to a water excess syndrome (Table 2) . Hypoosmolality may be unnoticed since a positive balance of 1 litre of water only decreases the serum sodium concentration by 3 mmol/l. Treatment of decreased urinary diluting capacity is of the primary cause and water restriction. In A.D.H. excess syndromes many of the drugs in Table 8 have been tried, but only demethylchlortetracycline (900 mg/d) has proved to be useful (Cherrill et al. 1975) .
A CLINICAL ApPROACH TO HYPER AND HyPO OSMOLAR SYNDROMES Generally these are synonymous with hyper and hyponatraemic syndromes. Since other solutes (glucose, urea or alcohol) do not affect the osmoreceptors, the serum sodium concentration is the best guide to "effective" osmolality.
Hyperosmolality
Water depletion only occurs when thirst mechanisms fail. Hyperosmolality does not Silverstein et al. (1975) Pohl, Thurston and Swales (1972) occur in the true and nephrogenic states of diabetes insipidus or with increased skin or lung insensible losses until intake is impaired.
Solute excess may be azotaemic, which is not associated with cellular dehydration; hyperglycaemic, where the effective osmolality is not increased until water depletion occurs; or hypernatraemic. Sodium excess occurs in unusual situations: seawater drowning, hypertonic sodium bicarbonate therapy, hyperadrenocorticoid states, and the use of salty feeds or incorrect dialysis fluid.
The effects of hyperosmolality per se are associated with those of the primary disease and, in water depletion, decreased cellular and extracellular volumes. The effects are probably largely mediated by brain dehydration (Arieff and Guisado 19i6) . Hence uraemia and alcohol intoxication cause hyperosmolality but not the classical encephalopathy.
Acute osmolar changes are more important than chronic ones, because if the hyperosmolality persists, brain cells generate osmotically active substances (idiogenic osmoles) and reduce cell dehydration (Holliday, Kalayci and Harrah 1968) . Brain deformation may tear vessels and be responsible for subdural and intracerebral haemorrhage (Finberg, Luttrell and Redd 1959) . Abnormal neurotransmitter release (Hubbard, Jones and Landau 1968), reduced energy production (Thurston et al. 19i5) or brain cell volume changes cause depression of sensorium and irritability which may progress to hypertonicity, twitching and convulsions.
The distinction between \vater depletion and sodium excess must be made clinically. Generallv the disturbance should be corrected over 48 -hours to avoid the risk of brain overhydration caused by the persistence of the "idiogenic osmoles". Seizures are common with more vigorous therapy (Smith et al. 19i4) .
Sodium excess can be treated by dialysis or with diuretics and replacement of urine volume with 5% dextrose. In water depletion the water deficit plus urine replacement and ongoing requirements can be given over 48 hours. If sodium depletion co-exists (e.g. with osmotic diuresis), hypotonic saline can be given, but increased hyperosmolality may occur (To and Phillips 19ii) . Frequent reassessment and monitoring of vital signs, continued urine loss, weight and serum electrolytes ensure smooth and gradual correction.
HYPoosJnolality
Spurious hyponatraemia may be caused by the presence of non aqueous solutes in serum (Waugh 1969) . If true hypoosmolality exists, it reflects water excess or sodium depletion. It is difficult to produce hyponatraemia by excess water intake if the osmolar load and diluting capacity are normal. However, patients with a low osmolar load and decreased diluting capacity are susceptible to water excess (Table 2) . Sodium depletion is distinguished clinically and may be caused by extrarenal or renal losses. Clinical assessment and measurement of urinary sodium concentration distinguishes the different causes (Philli ps 19i 5). Sodium losses are extrarenal if sodium depletion exists with appropriate renal sodium conservation. Renal sodium loss is commonly caused by diuretics and rarely by mineralocorticoid deficiency or intrinsic renal disease. In water excess syndromes caused by " appropriate" A.D.H. secretion an "appropriately" low urinary sodium concentration occurs «10 mmoljl). In those caused by " inappropriate" A.D.H. secretion or the other causes of impaired diluting capacity a high urinary sodium concentration occurs (>20 mmoljl). Problems of definitive biochemical diagnosis occur in patients on diuretics, but the clinical assessment and initial response to therapy is often diagnostic.
Hypoosmolality alone causes a variety of neurological syndromes ranging from dulled sensorium and nausea to coma and seizures. Abnormalities vary, but are related to the magnitude and rate of development of hypoosmolality. Hyponatraemia (serum sodium concentration <120 mmoljl) developing in animals over two hours is associated with coma, but developing over three days is asymptomatic (Arieff, Llach and l\fassry 19i6) . In general a serum sodium concentration <120 mmol/l is associated with neurological abnormalities which are only partly related to the development of cerebral oedema (Arieff and Guisado 19i6) .
Since acute severe hyponatraemia can cause irreversible brain damage (Arieff et al. ] 9i6) it should be corrected or symptoms relieved within ]2 hours. In less severe cases correction should be slower because vigorous therapy has risks of subdural or intracerebral haemorrhage and cardiac failure. Sodium deficits can be replaced with venous pressure monitoring. Fluid restriction «1 litre/d) is the mainstay of the treatment of water excess syndromes and allows gradual correction of hyponatraemia and a new steady state to develop. Hypertonic saline (1'8%-2i%), with diuretics to protect against extracellular volume overload, can be used in the emergency situation (Hantman et al. 19i3 ).
Anaesthesia and Intensive Care, Vol. V, No. 4, November, 1977 Long term management of A.D.H. excess is water restriction although demethylchlortetracycline may be useful.
